SCHEMBL1177397

SCHEMBL1177397

C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3CC(=O)C4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.78
USP2 O75604 2/20 0.78
NPC1L1 Q9UHC9 1/20 0.78
GPBAR1 Q8TDU6 7/20 0.70
MAPT P10636 2/20 0.70
THRB P10828 1/20 0.70
CASP7 P55210 3/20 0.69
TDP1 Q9NUW8 3/20 0.69
NR1H4 Q96RI1 3/20 0.69
TP53 P04637 2/20 0.69
MAPK1 P28482 2/20 0.69
HSD17B10 Q99714 2/20 0.69
BLM P54132 2/20 0.69
EPHA2 P29317 2/20 0.69
MDM4 O15151 1/20 0.69
CYP3A4 P08684 1/20 0.69
HSPD1 P10809 1/20 0.69
VDR P11473 1/20 0.69
TSHR P16473 1/20 0.69
PTPN2 P17706 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14360882 1.00 LMNA (0.78) LMNAUSP2NPC1L1GPBAR1MAPT
SCHEMBL18092664 1.00 LMNA (0.78) LMNAUSP2NPC1L1GPBAR1MAPT
SCHEMBL18092678 1.00 LMNA (0.78) LMNAUSP2NPC1L1GPBAR1MAPT
SCHEMBL3192872 1.00 LMNA (0.78) LMNAUSP2NPC1L1GPBAR1MAPT
SCHEMBL11406748 1.00 LMNA (0.78) LMNAUSP2NPC1L1GPBAR1MAPT
SCHEMBL1177394 1.00 LMNA (0.78) LMNAUSP2NPC1L1GPBAR1MAPT
SCHEMBL18092622 1.00 LMNA (0.78) LMNAUSP2NPC1L1GPBAR1MAPT
SCHEMBL11408265 0.90 USP2 (0.75) LMNAUSP2NPC1L1GPBAR1MAPT
SCHEMBL26653550 0.89 NPC1L1 (0.88) LMNAUSP2NPC1L1GPBAR1MAPT
SCHEMBL26653612 0.89 USP2 (0.81) LMNAUSP2NPC1L1GPBAR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3869192-B1 METHOD FOR QUANTITATIVE DETECTION OF VARIOUS METABOLITES IN BIOLOGICAL SAMPLE HUMAN METABOLOMICS INST INC (CN) 2026-05-13 EP claimed
US-20250258146-A1 QUANTITATIVE DETECTION METHOD OF MULTIPLE METABOLITES IN BIOLOGICAL SAMPLE AND METABOLIC CHIP HUMAN METABOLOMICS INSTITUTE INC. (CN) 2025-08-14 US claimed
CN-117630240-B Extraction and quantitative detection method of 87 bile acids in feces and intestinal contents 浙江大学 2024-09-03 CN claimed
EP-4133266-A1 IMPROVED METHODS FOR EVALUATING LIVER FUNCTION Hepquant, LLC (US) 2023-02-15 EP claimed
CN-113960221-B Method for detecting bile acid full-channel metabolic profile based on fecal sample and application thereof 中国中医科学院医学实验中心 2022-02-25 CN claimed
CN-113960222-B Serum sample-based bile acid full-channel metabolic profile detection method and application thereof 中国中医科学院医学实验中心 2022-02-25 CN claimed
US-20220026398-A1 QUANTITATIVE DETECTION METHOD OF MULTIPLE METABOLITES IN BIOLOGICAL SAMPLE AND METABOLIC CHIP HUMAN METABOLOMICS INSTITUTE INC. (CN) 2022-01-27 US claimed
CN-113960221-A Method for detecting bile acid full-channel metabolic profile based on fecal sample and application thereof 中国中医科学院医学实验中心 2022-01-21 CN claimed
CN-113960222-A Serum sample-based bile acid full-channel metabolic profile detection method and application thereof 中国中医科学院医学实验中心 2022-01-21 CN claimed
US-20210364526-A1 METHODS OF SELECTING SUBJECTS FOR TREATMENT WITH METABOLOMIC MODULATORS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2021-11-25 US claimed
US-20210318274-A1 METHODS FOR EVALUATING LIVER FUNCTION HepQuant, LLC 2021-10-14 US claimed
JP-10179153-A None JP disclosed
EP-3869192-B1 METHOD FOR QUANTITATIVE DETECTION OF VARIOUS METABOLITES IN BIOLOGICAL SAMPLE HUMAN METABOLOMICS INST INC (CN) 2026-05-13 EP disclosed
US-20250258146-A1 QUANTITATIVE DETECTION METHOD OF MULTIPLE METABOLITES IN BIOLOGICAL SAMPLE AND METABOLIC CHIP HUMAN METABOLOMICS INSTITUTE INC. (CN) 2025-08-14 US disclosed
CN-119823891-A Lactobacillus reuteri LRM2293 of Min swine origin and application thereof in anti-inflammatory reaction 东北农业大学 2025-04-15 CN disclosed
EP-1392725-A1 NONHUMAN PREGNANE X RECEPTOR SEQUENCES FOR USE IN COMPARATIVE PHARMACOLOGY SmithKline Beecham Corporation (US) 2004-03-03 EP disclosed
WO-2002094865-A1 NONHUMAN PREGNANE X RECEPTOR SEQUENCES FOR USE IN COMPARATIVE PHARMACOLOGY SMITHKLINE BEECHAM CORPORATION (US) 2002-11-28 WO disclosed
US-6274118-B1 INJECTING PATIENT HAVING ENDOCRINE CANCER IN NON-PROSTATIC TISSUE WITH BIOLOGICAL BINDING UNITS WHICH BIND TO PROSTATE SPECIFIC ANTIGEN PRODUCED BY NON-PROSTATIC TISSUE NORDION INTERNATIONAL INC. (CA) 2001-08-14 US disclosed
JP-H10179153-A 3-ALPHA-HYDROXYSTEROID DEHYDROGENASE AND IT PRODUCTION TOYOBO CO LTD 1998-07-07 JP disclosed
WO-1995002424-A1 LOCALIZATION AND THERAPY OF NON-PROSTATIC ENDOCRINE CANCER WITH AGENTS DIRECTED AGAINST PROSTATE SPECIFIC ANTIGEN NORDION INTERNATIONAL INC. (CA) 1995-01-26 WO disclosed